Top 10 ASX Dividend Stocks for Nov 2026 Download Free Report

Healthcare

Monash IVF Group Reports Embryo Transfer Error at Clayton Facility, Launches Expanded Investigation

Monash IVF Group Limited (ASX:MVF)is an ASX-listed healthcare company based in Australia, providing assisted reproductive services across clinics in Australia and Southeast Asia. The group offers a range of fertility, genetic, and diagnostic services to individuals and couples seeking fertility treatment.

Team Kalkine | 10 June 2025

EBR Systems Completes First Commercial U.S. Implants of WiSE® CRT System, Shares Rise Over 6%

EBR Systems, Inc. (ASX:EBR)has announced the successful completion of thefirst commercial U.S. implantationsof itsWiSE® cardiac resynchronization therapy (CRT) system, following recent approval by the U.S. Food and Drug Administration (FDA). The update marks a significant commercial milestone for the company and has boosted investor …

Team Kalkine | 06 June 2025

Integral Diagnostics Gets ‘Buy’ Tag from Analysts With Target Price of AUD 3.00

Integral Diagnostics Ltd (ASX:IDX) currently holds a “Buy” rating from analysts at Ord Minnett, with a target price of AUD 3.00, representing an upside potential of approximately 22.95% from its current price. Overall, the consensus recommendation mean stands at 1.64, translating to a "Buy" …

Team Kalkine | 02 June 2025

HealthCo REIT Shares Surge on Rent Deferral Deal and Hospital Sale Talks

Shares inHealthCo Healthcare and Wellness REIT (ASX:HCW)surged14.6% to 94.5 centsin early morning trade after the fund announced arent deferral agreementaimed at keeping hospital operatorHealthscopeafloat amid financial turmoil.

Team Kalkine | 30 May 2025

Clarity Pharmaceuticals Soars 10% After Imaging First Patient in Pivotal Phase III Prostate Cancer Trial

Shares ofClarity Pharmaceuticals Ltd (ASX: CU6)rallied 10% to$2.36on Thursday morning after the company announced it had successfully imaged the first patient in its Phase III AMPLIFY trial — a critical milestone in its quest to commercialise a breakthrough prostate cancer diagnostic.

Team Kalkine | 29 May 2025

Invion Shares Soar 53% After Promising Early Results in Skin Cancer Drug Trial

Shares of biotech firmInvion Limited (ASX:IVX)skyrocketed by 52.9% on Wednesday after the company released highly encouraging preliminary results from itsPhase I/II trialfor non-melanoma skin cancer (NMSC), showcasing the safety and early potential of its lead drug candidateINV043.

Team Kalkine | 29 May 2025

Fisher & Paykel Reports 43% Surge in FY2025 Profit, Projects Continued Growth for FY2026

Health equipment manufacturer Fisher & Paykel Healthcare Corporation Limited (ASX:FPH) announced a 43% increase in net profit after tax for the 2025 financial year, reaching NZ$377.2 million (US$348.1 million). The company attributed the surge to demand in its hospital consumables segment and masks used …

Team Kalkine | 28 May 2025

Neuren Pharmaceuticals (ASX: NEU) Shares Advance Following AGM Commentary

Neuren Pharmaceuticals Ltd (ASX: NEU) shares have risen today to AUD 13.72, reflecting a 2% increase in response to investor sentiment following the company's recent annual general meeting (AGM). At the meeting, management acknowledged investor frustration regarding the company’s share price, which has fallen …

Team Kalkine | 27 May 2025

AFT Pharma Expands U.S. Reach with Renewed Hikma Deal for Combogesic Products

New Zealand-basedAFT Pharmaceuticals (ASX:AFP)has deepened its partnership withHikma Pharmaceuticalsin a new 2025 deal that will significantly expand the reach of its flagshipCombogesicrange in the United States. The Auckland-headquartered drug maker announced the agreement extension to shareholders on Monday, describing the deal as a strategic …

Team Kalkine | 26 May 2025

Immutep Shares Climb on Cancer Trial Results Despite ASX 300 Lull

Shares of clinical-stage biotech Immutep Ltd (ASX:IMM) have jumped 3.4% to 30.5 cents in Monday morning trade, bucking the broader market trend and extending a the recovery for the stock since mid-April.

Team Kalkine | 26 May 2025
Support

Hi! How can we help you today?

Loading…